Stockscreener 앱 받기
1.81
7.74%
0.13
시간 외 거래:
1.70
-0.11
-6.08%
전일 마감가:
$1.68
열려 있는:
$1.65
하루 거래량:
209.66K
Relative Volume:
0.79
시가총액:
$9.20M
수익:
$755.00K
순이익/손실:
$-9.33M
주가수익비율:
-0.317
EPS:
-5.71
순현금흐름:
$-5.43M
1주 성능:
+1.69%
1개월 성능:
-1.63%
6개월 성능:
-27.02%
1년 성능:
-54.29%
1일 변동 폭
$1.65
$1.89
1주일 범위
$1.52
$1.89
52주 변동 폭
$1.485
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
MGRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.81 | 9.20M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
236.99 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.39 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.07 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
91.42 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.98 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Mangoceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
MGRX’s Market Ups and Downs: What’s Behind the 2023 Stock Performance? - investchronicle.com
Mangoceuticals Emerges as a Leader Amid Rapid Expansion of Oral Stimulant Pouch Market - InvestorNews
ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - InvestorNews
CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Gr - TradingView
Mangoceuticals acquires Smokeless Tech intellectual property - Investing.com
Mangoceuticals enters into agreement to acquire assets of Smokeless Technology - TipRanks
Mangoceuticals Acquires IP to Expand Product Line - TipRanks
Mangoceuticals acquires Smokeless Tech intellectual property By Investing.com - Investing.com South Africa
ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile
Mangoceuticals to Acquire Smokeless Technology's Intellectual Property - marketscreener.com
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - The Manila Times
Mangoceuticals Announces Strategic Entry into High Growth - GlobeNewswire
MangoRx Targets $37B Pouch Industry: Acquires Smokeless Tech IP, Lands Former JUUL President - Stock Titan
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions - Yahoo Finance
MGRX’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com
Trading Day Review: Mangoceuticals Inc (MGRX) Loses Momentum, Closing at 2.04 - DWinneX
What to expect from Mangoceuticals Inc’s (MGRX) current quarter earnings? - uspostnews.com
Can Mangoceuticals Inc (NASDAQ: MGRX) Still Be Hot This Week? - Stocksregister
Stock market nears its worst April in 93 years - The Globe and Mail
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Corsicana Daily Sun
Mangoceuticals Disrupts $33B Health Market: 5 Revolutionary Products Including FDA-Approved Treatments - Stock Titan
Mangoceuticals Issues Bonus Shares to Leadership - MSN
Mangoceuticals (NASDAQ:MGRX) Trading Down 10.3% – Time to Sell? - Defense World
MGRX stock touches 52-week low at $1.79 amid market challenges By Investing.com - Investing.com South Africa
MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com Canada
Why FedEx (FDX) Stock Is Nosediving - The Globe and Mail
Mangoceuticals issues new shares from preferred stock conversion - Investing.com India
Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa
Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater
Mangoceuticals Issues Common Stock in Exchange for Preferred - Investing.com Australia
Mangoceuticals Issues Common Stock in Exchange for Preferred By Investing.com - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 By Investing.com - Investing.com Australia
Mangoceuticals Inc (NASDAQ: MGRX) Stock: Bulls Should Watch This - Stocks Register
Mangoceuticals Expands into $33 Billion Addressable - GlobeNewswire
Mangoceuticals enters master distribution agreement for Diabetinol rights - TipRanks
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada - GlobeNewswire
Major Diabetes Market Breakthrough: Mangoceuticals Launches GLP-1 Alternative at Fraction of Cost - Stock Titan
Mangoceuticals Inc. (MGRX) reports earnings - Quartz
MANGOCEUTICALS, INC. SEC 10-K Report - TradingView
Mangoceuticals (NASDAQ:MGRX) Shares Up 18% – Time to Buy? - Defense World
Mangoceuticals Announces Equity and Leadership Changes By Investing.com - Investing.com Australia
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting - TipRanks
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mangoceuticals Inc 주식 (MGRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
0.24%
1.62%
자본화:
|
볼륨(24시간):